Home

Christopher Hite

CIK 1814238 · EVP & Chairman, Partnering · last filed 2026-07-02

Christopher Hite is an EVP & Chairman, Partnering who has filed 18 SEC Form 4 insider transactions across 4 companies since 2020. The most recent filing shows the insider sold $7.3M of RPRX on Jul 2, 2026. Across all open-market trades the lifetime net is −$13.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $29.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$29.95M

Companies

4

Total Filings

18

Lifetime Open-Market Net

-$13.54M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RPRX EVP & Chairman, Partnering 499,399 $59.97 $29.95M -$13.54M 12 2026-07-02
KLRA Director — $16.74 — $0 1 2026-04-20
VERA Director — $33.32 — $0 1 2026-03-09
ACCELERON PHARMA INC (XLRN) Delisted Director 0 $178.75 $0 $0 3 2021-11-22

Recent Filings

18 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-02 RPRX Sell (S) −130,000 -$7.35M EDGAR
2026-06-25 RPRX Sell (S) −150,000 -$8.16M EDGAR
2026-06-23 RPRX Notice (144) −30,000 -$1.66M EDGAR
2026-05-08 RPRX Grant (A) +24,263 $0 EDGAR
2026-04-20 KLRA Grant (A) — $0 EDGAR
2026-03-09 VERA Grant (A) — $0 EDGAR
2026-02-13 RPRX Grant (A) +26,626 $0 EDGAR
2025-11-07 RPRX Grant (A) +6,168 $0 EDGAR
2025-08-08 RPRX Grant (A) +3,696 $0 EDGAR
2025-05-20 RPRX Grant (A) — $0 EDGAR
Showing 1–10 of 18
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.